ESIH:LSE:LSE-iShares MSCI Europe Health Care Sector UCITS ETF (GBP)

ETF | Others |

Last Closing

USD 6.2185

Change

0.00 (0.00)%

Market Cap

USD 0.66B

Volume

2.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.15 (+0.41%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

-0.63 (-0.93%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

-2.50 (-1.25%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-2.16 (-1.72%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.19 (-1.05%)

USD 608.02B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.14 (-1.01%)

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

-29.25 (-1.44%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.39%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing ESIH:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.89% 83% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.89% 83% B 78% C+
Trailing 12 Months  
Capital Gain 15.15% 70% C- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.15% 69% C- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.22% 50% F 56% F
Dividend Return 4.22% 50% F 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.91% 83% B 91% A-
Risk Adjusted Return 85.95% 91% A- 94% A
Market Capitalization 0.66B 73% C 56% F

Annual Financials (GBP)

Quarterly Financials (GBP)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.